A new King’s College London study finds a cancer drug may reverse brain connectivity changes linked to early Alzheimer’s ...

Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the ...

For over thirty years, researchers have primarily studied the accumulation of amyloid beta proteins in the brains of Alzheimer’s patients. They also focus on how that component negatively impacts ...

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...

Alzheimer’s disease is characterized by certain key changes in the brain. Among them are the development of two kinds of protein deposits: clumps made up of amyloid beta and tangles of tau. These ...